1,025
Participants
Start Date
March 6, 2020
Primary Completion Date
July 31, 2021
Study Completion Date
July 31, 2021
Prospective Chart Review
Collected data will include demographic features, clinical characteristics, clinical outcome, medication use, COVID-19-related complications in patients with chronic liver disease.
Mount Sinai School of Medicine, New York
Weill Cornell Medicine, New York
University of Pittsburgh Medical Center, Pittsburgh
University of Pennsylvania, Philadelphia
Georgetown University, Washington D.C.
VA Medical Center, Washington D.C.
Duke University, Durham
University of Miami, Miami
University Hospitals Cleveland Medical Center, Cleveland
University of Michigan, Ann Arbor
Hennepin County Medical Center (HCMC), Minneapolis
University of Minnesota, Minneapolis
Rush University Medical Center, Chicago
The University of Kansas Medical Center, Kansas City
Oschner Medical Center, Baton Rouge
University of Arizona,, Phoenix
Mayo Clinic, Scottsdale
University of Southern California, Los Angeles
UCSF Fresno, Fresno
Stanford University, Stanford
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Stanford University
OTHER